Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Renal Cell Carcinoma Prior to Cytoreductive Nephrectomy
NCT00717587Phase 2Unknown
- Sponsor
- Abramson Cancer Center
- Start
- Jun 2008
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in renal cell carcinoma (RCC), sponsored by Abramson Cancer Center. Status: unknown.
02
Drugs
sunitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00717587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717587.